With chemical parks, innovative small companies and a network of internationally respected research institutes, Germany is a leading location in the chemicals and pharmaceutical industry.
In terms of investment and revenues, as well as applications for research and development, the German chemicals industry is the number one in Europe. With regard to exports, it is the world leader. All good reasons why top international industry events such as the chemical industry exhibition congress ACHEMA (every three years in Frankfurt, approx. 170,000 attendees) are regularly held in Germany. A special feature in Germany are the chemical parks – production facilities run by operating companies for a variety of organisations. Via a network of international pipelines, the parks are connected to the European trans-shipment centres for crude oil, natural gas and naphtha. In addition, the parks themselves are connected to each other via pipelines and excellent transport links. The German chemicals industry benefits from highly qualified staff, high levels of innovation and a strong research and development sector.
With regard to the number of companies and the creation of new, profitable intellectual property, the German biotechnology industry is one of the main driving forces in Europe. It is often small, flexible businesses that develop new medicines or diagnostic tests. Within the EU, Germany is the largest individual market for biopharmaceuticals, and ranks second in the world behind the USA. It also has proportionally more scientists with a PhD than the USA or Japan. Stimulating venues for business events are provided by internationally acclaimed scientific institutions such as the German Research Foundation, the Helmholtz Society, the Fraunhofer Institute, the Leibniz Association and the Max Planck Institute.